Your browser doesn't support javascript.
loading
A Novel Therapeutic Anti-ErbB3, ISU104 Exhibits Potent Antitumorigenic Activity by Inhibiting Ligand Binding and ErbB3 Heterodimerization.
Hong, Mirim; Yoo, Youngki; Kim, Miyoung; Kim, Ju Yeon; Cha, Jeong Seok; Choi, Myung Kyung; Kim, Uijin; Kim, Kyungyong; Sohn, Youngsoo; Bae, Donggoo; Cho, Hyun-Soo; Hong, Seung-Beom.
Afiliação
  • Hong M; Research Institute, ISU ABXIS Co., Ltd., Sungnam-si, Republic of Korea (South).
  • Yoo Y; Department of Systems Biology, Yonsei University, Seoul, Republic of Korea (South).
  • Kim M; Research Institute, ISU ABXIS Co., Ltd., Sungnam-si, Republic of Korea (South).
  • Kim JY; Research Institute, ISU ABXIS Co., Ltd., Sungnam-si, Republic of Korea (South).
  • Cha JS; Department of Systems Biology, Yonsei University, Seoul, Republic of Korea (South).
  • Choi MK; Department of Systems Biology, Yonsei University, Seoul, Republic of Korea (South).
  • Kim U; Department of Systems Biology, Yonsei University, Seoul, Republic of Korea (South).
  • Kim K; Research Institute, ISU ABXIS Co., Ltd., Sungnam-si, Republic of Korea (South).
  • Sohn Y; Research Institute, ISU ABXIS Co., Ltd., Sungnam-si, Republic of Korea (South).
  • Bae D; Research Institute, ISU ABXIS Co., Ltd., Sungnam-si, Republic of Korea (South).
  • Cho HS; Department of Systems Biology, Yonsei University, Seoul, Republic of Korea (South). hongsb@isu.co.kr hscho8@yonsei.ac.kr.
  • Hong SB; Research Institute, ISU ABXIS Co., Ltd., Sungnam-si, Republic of Korea (South). hongsb@isu.co.kr hscho8@yonsei.ac.kr.
Mol Cancer Ther ; 20(6): 1142-1152, 2021 06.
Article em En | MEDLINE | ID: mdl-33782100
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptor ErbB-3 / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptor ErbB-3 / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2021 Tipo de documento: Article